Clinical Trials Directory

Trials / Completed

CompletedNCT03496103

Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber

Induction of Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
29 (actual)
Sponsor
The University of Texas Medical Branch, Galveston · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

In this study subjects self recorded nasal and ocular symptoms scores from exposure to ragweed pollen in an Allergen Challenge Chamber (ACC). This single site study of seasonal allergic rhinitis was designed to enroll up to 35 participants. These participants would be age 18-70, male and female, with a mixture of ethnic groups. The study would involve 2 phases: Screening and Exposure. In the Exposure phase, participants were exposed to pollen for up to 180 minutes.

Detailed description

This was a study to evaluate self recorded nasal and ocular allergy symptom scores from exposure to ragweed pollen in an Allergen Challenge Chamber (ACC). This single site study of seasonal allergic rhinitis was designed to enroll up to 35 participants. These participants would be age 18-70, male and female, with a mixture of ethnic groups. The study would involve 2 phases: Screening and Exposure. In the Exposure phase, participants were exposed to pollen for up to 180 minutes. For allergic participants, qualification symptom scores at 120 minutes of exposure determined if ACC exposure would be continued.

Conditions

Interventions

TypeNameDescription
BIOLOGICALragweed pollenthree hours ragweed pollen in a allergen exposure chamber

Timeline

Start date
2016-02-29
Primary completion
2016-03-12
Completion
2016-03-12
First posted
2018-04-12
Last updated
2018-04-12

Source: ClinicalTrials.gov record NCT03496103. Inclusion in this directory is not an endorsement.